The Nelson A. Rockefeller Center for Public Policy and the Social Sciences

David F. Squire ’47 Named Intern

NOTES FROM THE FIELD: FAVEN WOLDETATYOS '20

Faven Woldetatyos '20 interned at The Borgen Project during the 2020 summer term. The following is an excerpt from her internship report.

NOTES FROM THE FIELD: RAAM TAMBE '21

Raam Tambe '21 interned at Swing Left during the 2020 summer term. The following is an excerpt from his internship report.

NOTES FROM THE FIELD: MICHAEL CLEARY '21

Michael Cleary '21 interned at the International Literacy and Development during the 2020 summer term. The following is an excerpt from his internship report.

Over the summer, I was an intern with International Literacy and Development, a medium-sized Texas-based nonprofit focused on economic and literacy development in a range of low-income countries in Africa, Asia, and the Americas. My path to that role began years ago, when I first began to take some classes at Dartmouth focused on languages and on economic development. For my final off-term as a Dartmouth student, I applied to ILAD, hoping to get some real-world experience within the field of economic development.

Notes From the Field: Brittany Cleary ’21

Brittany Cleary ’21 interned at Planned Parenthood of Southern New England (PPSNE) during the 2018 Summer Term. The following if an excerpt from her internship report.

 

This summer, I interned at Planned Parenthood of Southern New England (PPSNE), an affiliate of Planned Parenthood Federation of America (PPFA), is a nonprofit organization that provides vital reproductive health services to women (and men) regardless of their race, ethnicity, socioeconomic status, religion, and background. Beyond providing healthcare to thousands of patients, PPSNE boasts the second most robust clinical research program among the PPFA affiliates. When companies pioneer new technology to improve medical diagnosis and treatment, they will commission PPSNE to recruit patients and collect samples for clinical research studies to prove to the Federal Drug Administration (FDA) that their new innovations are valid and reliable.

 

Close
The Nelson A. Rockefeller Center for Public Policy and the Social Sciences